FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

387003001: Trastuzumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461181011 Trastuzumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481117012 Trastuzumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
Trastuzumab Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Trastuzumab Has disposition Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Trastuzumab Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Trastuzumab Is a Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Trastuzumab Has disposition Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Existential restriction modifier
Trastuzumab Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier
Trastuzumab Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Trastuzumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Kanjinti 150mg powder for concentrate for solution for infusion vials (Amgen Ltd) 1 vial Has specific active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Trastuzumab 420mg powder for solution for infusion vials Has active ingredient False Trastuzumab Inferred relationship Existential restriction modifier
Trastuzumab 420mg powder for solution for infusion vials Has specific active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Kanjinti 420mg powder for concentrate for solution for infusion vials (Amgen Ltd) Has active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Kanjinti 420mg powder for concentrate for solution for infusion vials (Amgen Ltd) Has specific active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Trastuzumab 420mg powder for solution for infusion vials 1 vial Has specific active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Kanjinti 420mg powder for concentrate for solution for infusion vials (Amgen Ltd) 1 vial Has specific active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Herzuma 420mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) Has active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Herzuma 420mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) Has specific active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Herzuma 420mg powder for concentrate for solution for infusion vials (Celltrion Healthcare UK Ltd) 1 vial Has specific active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) Has basis of strength substance True Trastuzumab Inferred relationship Existential restriction modifier 1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) Has precise active ingredient True Trastuzumab Inferred relationship Existential restriction modifier 1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) Has specific active ingredient True Trastuzumab Inferred relationship Existential restriction modifier
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) 1 vial Has basis of strength substance True Trastuzumab Inferred relationship Existential restriction modifier 1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) 1 vial Has precise active ingredient True Trastuzumab Inferred relationship Existential restriction modifier 1
Trazimera 150mg powder for concentrate for solution for infusion vials (Pfizer Ltd) 1 vial Has specific active ingredient True Trastuzumab Inferred relationship Existential restriction modifier

Start Previous Page 5 of 5

This concept is not in any reference sets

Back to Start